Neurobiology and genetics of generalized anxiety disorder

Psychiatric Annals

Volumn 41, Issue 2, 2011, Pages 111-123

  Schienle, Anne ^a   Hettema, John M ^b   Cáceda, Ricardo ^c   Nemeroff, Charles B ^c  

^a UNIVERSITY OF GRAZ   (Austria)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951626976     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20110203-10     Document Type: Article

References (104)

1. De Bellis MD, Keshavan MS, Shifflett H, et al. Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry. 2002;51(7):553-562.
2. De Bellis MD, Casey BJ, Dahl RE, et al. A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol Psychiatry. 2000;48(1):51-57.
3. Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry. 2009;66(12):1361-1372.
4. Milham MP, Nugent AC, Drevets WC, et al. Selective reduction in amygdala volume in pediatric anxiety disorders: a voxel-based morphometry investigation. Biol Psychiatry. 2005;57(9):961-966.
5. Schienle A, Kochel A, Ebner F, Reishofer G, Schafer A. Neural correlates of intolerance of uncertainty. Neurosci Lett. 2010;479(3):272-276.
6. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28(6):487-495.
7. Mathew SJ, Price RB, Shungu DC, et al. A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder. J Psychopharmacol. 2010;24(8):1175-1181.
8. Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specifi c phobia. Am J Psychiatry. 2007;164(10):1476-1488.
9. Etkin A. Functional neuroanatomy of anxiety: a neural circuit perspective. In: Stein MB, Steckler T, eds. Behavioral neurobiology of anxiety and its treatment. Curr Topics in Behav Neurosci. 2010;251-277.
10. Etkin A, Prater KE, Hoeft F, Menon V, Schatzberg AF. Failure of anterior cingulated activation and connectivity with the amygdale during implicit regulation of emotional processing in generalized anxiety disorder. Am J Psychiatry. 2010;167(5):545-554.
11. Hoehn-Saric R, Schlund MW, Wong SH. Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder. Psychiatry Res. 2004;131(1):11-21.
12. Paulesu E, Sambugaro E, Torti T, et al. Neural correlates of worry in generalized anxiety disorder and in normal controls: a functional MRI study. Psychol Med. 2010;40:117-124.
13. Kober H, Barrett LF, Joseph J, et al. Functional grouping and cortical-subcortical interactions in emotion: a meta-analysis of neuroimaging studies. Neuroimage. 2008;42(2):998-1031.
14. Nitschke JB, Sarinopoulos I, Oathes DJ, et al. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry. 2009;166(3):302-310.
15. Whalen PJ, Johnstone T, Somerville LH, et al. A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biol Psychiatry. 2008;63(9):858-863.
16. Maslowsky J, Mogg K, Bradley BP, et al. A preliminary investigation of neural correlates of treatment in adolescents with generalized anxiety disorder. J Child Adolesc Psychopharmacol. 2010;20(2):105-111.
17. Kalisch R, Wiech K, Critchley HD, Dolan RJ. Levels of appraisal: a medial prefrontal role in high-level appraisal of emotional material. Neuroimage. 2006;30(4):1458-1466.
18. Abler B, Erk S, Herwig U, Walter H. Anticipation of aversive stimuli activates extended amygdala in unipolar depression. J Psychiatr Res. 2007;41(6):511-522.
19. Schienle A, Ebner F, Schafer A. Localized gray matter volume abnormalities in generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci. September 5, 2010.
20. Nemeroff CB. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull. 2003;37(4):133-146.
21. Weizman R, Tanne Z, Granek M, et al. Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients. Eur J Pharmacol. 1987;138(2):289-292.
22. Tiihonen J, Kuikka J, Rasanen P, et al. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis. Mol Psychiatry. 1997;2(6):463-471.
23. Nikolaus S, Antke C, Beu M, Muller HW. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders - results from in vivo imaging studies. Rev Neurosci. 2010;21(2):119-139.
24. Nutt DJ. Neurobiological mechanisms in generalized anxiety disorder. J Clin Psychiatry. 2001; 62(Suppl 11):22-27; discussion 28.
25. Mathew SJ, Amiel JM, Coplan JD, et al. Open-label trial of riluzole in generalized anxiety disorder. Am J Psychiatry. 2005;162(12):2379-2381.
26. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1):85-102.
27. Brewerton TD. Toward a unifi ed theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology. 1995;20(6):561-590.
28. Daekin JF, Graeff FG. 5-HT and mechanisms of defence. J Psychopharmacol. 1991:305-315.
29. Germine M, Goddard AW, Woods SW, Charney DS, Heninger GR. Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder. Biol Psychiatry. 1992;32(5):457-461.
30. Iny LJ, Pecknold J, Suranyi-Cadotte BE, et al. Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets. Biol Psychiatry. 1994;36(5):281-291.
31. Maron E, Kuikka JT, Ulst K, et al. SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci. 2004;254(6):392-396.
32. Kelly CB, Cooper SJ. Differences and variability in plasma noradrenaline between depressive and anxiety disorders. J Psychopharmacol. 1998;12(2):161-167.
33. Khan A, Lee E, Dager S, Hyde T, et al. Platelet MAO-B activity in anxiety and depression. Biol Psychiatry. 1986;21:847-849.
34. Mathew RJ, Ho BT, Taylor D. Dopaminebeta-hydroxylase response to epinephrine injection in anxious patients and normals. Biol Psychiatry. 1982;17(8-9):393-397.
35. Abelson JL, Glitz D, Cameron OG, et al. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. Arch Gen Psychiatry. 1991;48(2):157-162.
36. Charney DS, Woods SW, Heninger GR. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder. Psychiatry Res. 1989;27(2):173-182.
37. Brawman-Mintzer O, Lydiard RB, Bradwejn J, et al. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. Am J Psychiatry. 1997;154(5):700-702.
38. Pande AC, Greiner M, Adams JB, Lydiard RB, Pierce MW. Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder. Biol Psychiatry. 1999;46(6):860-862.
39. Goddard AW, Woods SW, Money R, et al. Effects of the CCK(B) antagonist CI-988 on responses to m CPP in generalized anxiety disorder. Psychiatry Res. 1999;85(3):225-240.
40. Adams JB, Pyke RE, Costa J, et al. A doubleblind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder. J Clin Psychopharmacol. 1995;15(6):428-434.
41. Jetty PV, Charney DS, Goddard AW. Neurobiology of generalized anxiety disorder. Psychiatr Clin North Am. 2001;24(1):75-97.
42. Sajdyk TJ, Shekhar A, Gehlert DR. Interactions between NPY and CRF in the amygdale to regulate emotionality. Neuropeptides. 2004;38(4):225-234.
43. Fossey MD, Lydiard RB, Ballenger JC, et al. Cerebrospinal fl uid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects. Biol Psychiatry. 1996;39(8):703-707.
44. Holsboer F, Ising M. Central CRH system in depression and anxiety - evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol. 2008;583(2-3):350-357.
45. Tiller JW, Biddle N, Maguire KP, Davies BM. The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder. Biol Psychiatry. 1988;23(3):261-270.
46. Staner L, Linkowski P, Mendlewicz J. Biological markers as classifiers for depression: a multivariate study. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18(5):899-914.
47. Lenze EJ, Mantella RC, Shi P, et al. Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram. Am J Geriatr Psychiatry. Aug. 11, 2010.
48. Tsigos C, Chrousos GP. Hypothalamicpituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865-871.
49. Cameron OG, Nesse RM. Systemic hormonal and physiological abnormalities in anxiety disorders. Psychoneuroendocrinology. 1988;13(4):287-307.
50. Semeniuk T, Jhangri GS, Le Melledo JM. Neuroactive steroid levels in patients with generalized anxiety disorder. J Neuropsychiatry Clin Neurosci. 2001;13(4):396-398.
51. Cooper MA, Ritchie EC. Testosterone replacement therapy for anxiety. Am J Psychiatry. 2000;157(11):1884.
52. Kaneda Y, Fujii A. Effects of tandospirone, a serotonin-1A agonist, on the hypothalamo-pituitary-gonadal axis of male patients. Neuro Endocrinol Lett. 2001;22(4):243-247.
53. Barger SD, Sydeman SJ. Does generalized anxiety disorder predict coronary heart disease risk factors independently of major depressive disorder? J Affect Disord. 2005;88(1):87-91.
54. Shibeshi WA, Young-Xu Y, Blatt CM. Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol. 2007;49(20):2021-2027.
55. Barlow DH, Wincze J. DSM-IV and beyond: what is generalized anxiety disorder? Acta Psychiatr Scand. 1998; (Suppl 393): 23-29.
56. Goldberg D, Kendler KS, Sirovatka, PJ, Regier DA, eds. Diagnostic Issues in Depression and Generalized Anxiety Disorder. Arlington, VA: American Psychiatric Publishing; 2010.
57. Hettema JM. The nosologic relationship between generalized anxiety disorder and major depression. Depress Anxiety. 2008;25(4):300-316.
58. Di Nardo P, Moras K, Barlow DH, Rapee RM, Brown TA. Reliability of DSM-III-R anxiety disorder categories. Using the Anxiety Disorders Interview Schedule-Revised (ADIS-R). Arch Gen Psychiatry. 1993;50(4):251-256.
59. Goldenberg IM, White K, Yonkers K, et al. The infrequency of "pure culture" diagnoses among the anxiety disorders. J Clin Psychiatry. 1996;57(11):528-533.
60. Judd LL, Kessler RC, Paulus MP, et al. Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS). Acta Psychiatr Scand. 1998;393:6-11.
61. Newman SC, Bland RC. A populationbased family study of DSM-III generalized anxiety disorder. Psychol Med. 2006;36(9):1275-1281.
62. Neale MC, Cardon LR. North Atlantic Treaty Organization. Scientifi c Affairs Division. Methodology for Genetic Studies of Twins and Families. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1992.
63. Torgersen S. Genetic factors in anxiety disorders. Arch Gen Psychiatry. 1983;40(10):1085-1089.
64. Skre I, Onstad S, Torgersen S, Lygren S, Kringlen E. A twin study of DSM-III-R anxiety disorders. Acta Psychiatr Scand. 1993;88(2):85-92.
65. Andrews G, Stewart G, Allen R, Henderson AS. The genetics of six neurotic disorders: a twin study. J Affect Disord. 1990;19(1):23-29.
66. Kendler KS, Prescott CA. Genes, Environment, and Psychopathology: Understanding the Causes of Psychiatric and Substance Use Disorders. New York, NY: Guilford Press; 2006.
67. Eisen S, True W, Goldberg J, Henderson W, Robinette CD. The Vietnam Era Twin (VET) Registry: method of construction. Acta Genet Med Gemellol (Roma). 1987;36(1):61-66.
68. Lichtenstein P, Sullivan PF, Cnattingius S, et al. The Swedish Twin Registry in the third millennium: an update. Twin Res Hum Genet. 2006;9(6):875-882.
69. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Generalized anxiety disorder in women. A population-based twin study. Arch Gen Psychiatry. 1992;49(4):267-272.
70. Hettema JM, Prescott CA, Kendler KS. A population-based twin study of generalized anxiety disorder in men and women. J Nerv Ment Dis. 2001;189(7):413-420.
71. Scherrer JF, True WR, Xian H, et al. Evidence for genetic infl uences common and specifi c to symptoms of generalized anxiety and panic. J Affect Disord. 2000;57(1-3):25-35.
72. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158(10):1568-1578.
73. Roy MA, Neale MC, Pedersen NL, Mathe AA, Kendler KS. A twin study of generalized anxiety disorder and major depression. Psychol Med. 1995;25(5):1037-1049.
74. Klein DN, Riso LP. Psychiatric disorders: problems of boundaries and comorbidity. In: Cotello CG, eds. Basic Issues in Psychopathology. New York, NY: Guilford Press;1993:19-66.
75. Reich J. Family psychiatric histories in male patients with generalized anxiety disorder and major depressive disorder. Ann Clin Psychiatry. 1995;7(2):71-78.
76. Kendler KS, Davis CG, Kessler RC. The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study. Br J Psychiatry. 1997;170:541-548.
77. Kendler KS. Major depression and generalized anxiety disorder. Same genes, (partly)different environments - revisited. Br J Psychiatry. 1996;30:68-75.
78. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry. 1992;49(9):716-722.
79. Kato K, Sullivan PF, Evengard B, Pedersen NL. A population-based twin study of functional somatic syndromes. Psychol Med. 2009;39(3):497-505.
80. Hettema JM, Prescott CA, Myers JM, Neale MC, Kendler KS. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry. 2005;62(2):182-189.
81. Tambs K, Czajkowsky N, Roysamb E, et al. Structure of genetic and environmental risk factors for dimensional representations of DSM-IV anxiety disorders. Br J Psychiatry. 2009;195(4):301-307.
82. Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60(9):929-937.
83. Cosgrove VE, Rhee SH, Gelhorn HL, et al. Structure and etiology of co-occurring internalizing and externalizing disorders in adolescents. J Abnorm Child Psychol. Aug. 4, 2010.
84. Chantarujikapong SI, Scherrer JF, Xian H, et al. A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men. Psychiatry Res. 2001;103(2-3):133-145.
85. Andrews G, Stewart G, Morris-Yates A, Holt P, Henderson S. Evidence for a general neurotic syndrome. Br J Psychiatry. 1990;157:6-12.
86. Bienvenu OJ, Brown C, Samuels JF, et al. Normal personality traits and comorbidity among phobic, panic and major depressive disorders. Psychiatry Res. 2001;102(1):73-85.
87. Hettema JM, Prescott CA, Kendler KS. Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. Am J Psychiatry. 2004;161(9):1581-1587.
88. Mackintosh MA, Gatz M, Wetherell JL, Pedersen NL. A twin study of lifetime Generalized anxiety disorder (GAD) in older adults: genetic and environmental influences shared by neuroticism and GAD. Twin Res Hum Genet. 2006;9(1):30-37.
89. Kendler KS, Gardner CO, Gatz M, Pedersen NL. The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med. 2007;37(3):453-462.
90. Hettema JM, Neale MC, Myers JM, Prescott CA, Kendler KS. A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry. 2006;163(5):857-864.
91. Maron E, Hettema JM, Shlik J. Advances in molecular genetics of panic disorder. Mol Psychiatry. 2010;15(7):681-701.
92. Rowe DC, Stever C, Gard JM, Cleveland HH, et al. The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behav Genet. 1998;28(3):215-225.
93. Ohara K, Suzuki Y, Ochiai M, Tsukamoto T, Tani K. A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23(1):55-65.
94. Tadic A, Rujescu D, Szegedi A, et al. Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet B Neuropsychiatr Genet. 2003;117B:1-6.
95. Samochowiec J, Hajduk A, Samochowiec A, et al. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res. 2004;128(1):21-26.
96. You JS, Hu SY, Chen B, Zhang HG. Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder. Psychiatr Genet. 2005;15(1):7-11.
97. Koenen KC, Amstadter AB, Ruggiero KJ, et al. RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety. 2009;26(4):309-315.
98. Amstadter AB, Koenen KC, Ruggiero KJ, et al. NPY moderates the relation between hurricane exposure and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety. 2010;27(3):270-275.
99. Hettema JM, An SS, Neale MC, et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry. 2006;11(8):752-762.
100. Hettema JM, An SS, Bukszar J, et al. Catechol- O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biol Psychiatry. 2008;64(4):302-310.
101. Noyes R Jr., Clarkson C, Crowe RR, Yates WR, McChesney CM. A family study of generalized anxiety disorder. Am J Psychiatry. 1987;144(8):1019-1024.
102. Mendlewicz J, Papadimitriou G, Wilmotte J. Family study of panic disorder - comparison with generalized anxiety disorder, major depression and normal subjects. Psychiatr Genet. 1993;3:73-78.
103. Newman SC, Bland RC. A population-based family study of DSM-III generalized anxiety disorder. Psychol Med. 2006;36(9):1275-1281.
104. Coelho HF, Cooper PJ, Murray L. A family study of co-morbidity between generalized social phobia and generalized anxiety disorder in a non-clinic sample. J Affect Disord. 2007;100(1-3):103-113.